Literature DB >> 2431610

Substance P, a neuropeptide, inhibits measles virus replication in cell culture.

C Schroeder.   

Abstract

Substance P, a neuropeptide of the tachykinin group, inhibits measles virus replication in cell culture and partially blocks viral fusion activity assayed in the haemolysis system. The ID50 for the inhibition of measles virus single-cycle replication is 0.6 mumol/l, and the effect is fully reversible. The antiviral activity of substance P corresponds to that of previously described synthetic tri-to heptapeptides. Tachykinins and these oligopeptides share a short homology with the N-terminus of paramyxovirus fusion proteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431610

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  5 in total

1.  Measles virus-substance P receptor interactions. Possible novel mechanism of viral fusion.

Authors:  G Harrowe; M Mitsuhashi; D G Payan
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

2.  Neurokinin-1 enables measles virus trans-synaptic spread in neurons.

Authors:  Nina R Makhortova; Peter Askovich; Catherine E Patterson; Lisa A Gechman; Norma P Gerard; Glenn F Rall
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

3.  CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus.

Authors:  S Löffler; F Lottspeich; F Lanza; D O Azorsa; V ter Meulen; J Schneider-Schaulies
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

4.  Measles virus-substance P receptor interaction: Jurkat lymphocytes transfected with substance P receptor cDNA enhance measles virus fusion and replication.

Authors:  G Harrowe; J Sudduth-Klinger; D G Payan
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

5.  Characterization of substance P binding to human monocytes/macrophages.

Authors:  D R Lucey; J M Novak; V R Polonis; Y Liu; S Gartner
Journal:  Clin Diagn Lab Immunol       Date:  1994-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.